Cargando…
Tertiary drug information sources for treatment and prevention of COVID-19
OBJECTIVE: To evaluate tertiary drug information databases in terms of scope, consistency of content, and completeness of COVID-19 drug information. METHODS: Five electronic drug information databases: Clinical Pharmacology, Lexi-Drugs, AHFS DI (American Hospital Formulary Service Drug Information),...
Autores principales: | Beckett, Robert D., Brattain, Yashawna, Truong, Judy, Engle, Genevieve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University Library System, University of Pittsburgh
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621729/ https://www.ncbi.nlm.nih.gov/pubmed/37928123 http://dx.doi.org/10.5195/jmla.2023.1662 |
Ejemplares similares
-
Off-label use information in electronic drug information resources
por: Rothgeb, Amanda, et al.
Publicado: (2022) -
Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions
por: Beckett, Robert D., et al.
Publicado: (2019) -
Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse
por: Beckett, Robert D., et al.
Publicado: (2020) -
Mothers’ Sources of Child Fluoride Information and Misinformation From Social Connections
por: Burgette, Jacqueline M., et al.
Publicado: (2022) -
Prevalence and Sources of Duplicate Information in the Electronic Medical Record
por: Steinkamp, Jackson, et al.
Publicado: (2022)